Table 4.
Outcomes of All Patients
| Clinically Significant Events Requiring Treatment | N, % | BMI < 30 (n = 117) | BMI ≥ 30 (n = 80) | P | |
|---|---|---|---|---|---|
| EMCa recurrence (including pT2,3) | 5 | 2.5% | 3 | 2 | 1.0 |
| Cancer-specfic death | 2 | 1% | 2 | 0 | |
| Disease-free survival | 3 | 1.5% | 1 | 2 | |
| Other organ cancer | 6 | 3% | 5 | 1* | 0.429 |
| Lifestyle-related diseases | 11 | 5.6% | 3 | 8 | 0.055 |
| Initiation of dialysis | 2 | 1% | 2 | 0 | |
| Thrombosis | 2 | 1% | 0 | 2 | |
| Diabetes, liver disease, etc | 7 | 3.5% | 1 | 6 | |
| Fractures/orthopedic surgery | 3 | 1.5% | 1 | 2 | - |
| Others | 2 | 1% | 2 | 0 | - |
| Total | 27 | 13 | 14 | ||
EMCa endometrial cancer, A A patient with a BMI of 53 developed lung cancer. Subsequently, their BMI increased to 60, leading to worsening respiratory impairment due to severe obesity. This made treatment challenging, and the patient unfortunately passed away